A multicenter, randomized study to evaluate the efficacy and safety of mesalamine suppositories 1 g at bedtime and 500 mg Twice daily in patients with active mild-to-moderate ulcerative proctitis.
Dig Dis Sci
; 56(2): 513-22, 2011 Feb.
Article
in En
| MEDLINE
| ID: mdl-20676771
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proctitis
/
Mesalamine
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Dig Dis Sci
Year:
2011
Document type:
Article
Affiliation country:
United States
Country of publication:
United States